US Patent

US11344512 — Titration of tapentadol

Method of Use · Assigned to Gruenenthal GmbH · Expires 2028-04-21 · 2y remaining

Vulnerability score 83/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method of using tapentadol for pain treatment involving a medicament with two administration units of different doses.

USPTO Abstract

The use of tapentadol for the manufacture of a medicament comprising at least one administration unit A containing dose a of tapentadol and at least one administration unit B containing dose b of tapentadol, where dose a<dose b, for the treatment of pain.

Drugs covered by this patent

tapentadol-hydrochloride (TAPENTADOL HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3392`	—	tapentadol-hydrochloride
`U-3392`	—	tapentadol-hydrochloride
`U-3392`	—	tapentadol-hydrochloride
`U-3391`	—	tapentadol-hydrochloride
`U-3392`	—	tapentadol-hydrochloride

Patent Metadata

Patent number: US11344512
Jurisdiction: US
Classification: Method of Use
Expires: 2028-04-21
Drug substance claim: No
Drug product claim: No
Assignee: Gruenenthal GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.